[Association of nitrogen mustard, vincristine, methylhydrazine and prednisone in treatment of diffuse forms of Hodgkin's disease and ganglionic sarcomas].
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004357:Drug Synergism; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use*
D006834:Hydrazines; D009588:Nitrogen Mustard Compounds; D014750:Vincristine; D011241:Prednisone
L'association moutarde à l'azote, vincristine, méthylhydrazine et prednisone dans le traitement des formes diffuses de la maladie de Hodgkin et des sarcomes ganglionnaires.